Literature DB >> 7391617

Colitis associated with metronidazole therapy.

R Saginur, C R Hawley, J G Bartlett.   

Abstract

A 46-year-old woman was treated with oral metronidazole for trichomonal vaginitis and developed diarrhea, which persisted for five weeks. Tissue culture assay of stool supernatant showed a cytopathic toxin that was neutralized by Clostridium sordellii antitoxin, and cultures yielded Clostridium difficile, which produced a similar or identical cytotoxin in vitro. This isolate proved sensitive to metronidazole at 0.25 microgram/ml. Prior reports have indicated that metronidazole may also be used therapeutically in patients with antibiotic-associated colitis ascribed to other agents. The patient presented here shows the enigma that the same agent used for therapy of colitis may also cause this complication.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391617     DOI: 10.1093/infdis/141.6.772

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Clostridium difficile colitis in children with cystic fibrosis.

Authors:  Sunny Zaheed Hussain; Cathy Chu; David P Greenberg; David Orenstein; Seema Khan
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

2.  Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.

Authors:  B A Walters; R Roberts; R Stafford; E Seneviratne
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

3.  Pseudomembranous colitis secondary to metronidazole.

Authors:  J J Daly; K V Chowdary
Journal:  Dig Dis Sci       Date:  1983-06       Impact factor: 3.199

4.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Evaluation of eight cephalosporins in hamster colitis model.

Authors:  J R Ebright; R Fekety; J Silva; K H Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  Treatment of Clostridium difficile Infection.

Authors:  John R. Stroehlein
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

Review 7.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

8.  Antibiotic-associated colitis and cystic fibrosis.

Authors:  C S Pokorny; P T Bye; C MacLeod; W S Selby
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

9.  Clostridium difficile colitis following treatment with metronidazole and vancomycin.

Authors:  P J Bingley; G M Harding
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.